論文
Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Fujimura T, Tsuda H, Osaki A, Saeki T, Inoue S.
Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer.
J Steroid Biochem Mol Biol. 123: 1-7. 2011
Kamisasanuki T, Wang Y, Tokushige S, Terasaki H, Khai NC, Wang Y,
Sakamoto T, Kosai K.
Targeting CD9 produces stimulus-independent antiangiogenic effects
predominantly in activated endothelial cells during angiogenesis: A novel
antiangiogenic therapy.
Biochem. Biophys. Res. Commun. 16;413(1):128-35, 2011
Horikawa Y, Wang Y, Nagano S, Kamizono J, Ikeda M, Komiya S, Kosai K.
Assessment of an altered E1B promoter on the specificity and potency of
triple-regulated conditionally replicating adenoviruses (CRA) ⎯Implications
for the generation of ideal m-CRAs.
Cancer Gene Ther 18(10):724-33, 2011
Khai NC, Sakamoto K, Takamatsu H, Matsufuji H, Kosai K.
Recombinant soluble form of HB-EGF protein therapy drastically
inhibits Fas-mediated fulminant hepatic failure: Implications in clinical
application.
Hepatol Res. 41:594-596, 2011.
Murakami KI, Kaji T, Shimono R, Hyashida Y, Matsufuji H, Tsuyama S,
Maezono R, Kosai K, Takamatsu H.
Therapeutic effects of vitamin A on experimental cholestatic rats with
hepatic fibrosis.
Pediatr Surg Int. 27(8):863-70, 2011.
Fujimura T, Takahashi S, Urano T, Ijichi N, Ikeda K, Kumagai J, Murata T, Takayama K, Horie-Inoue K, Ouchi Y, Muramatsu M, Homma Y, Inoue S.
Differential expression of estrogen-related receptors β and γ (ERRβ and ERRγ) and their clinical significance in human prostate cancer.
Cancer Sci. 101: 646-651, 2010
Okabe Y, Kusanaga A, Takahashi T, Mitsumasu C, Murai Y, Tanaka E,
Higashi H, Matsuishi T, Kosai K.
Neural Development of Methyl-CpG-Binding Protein 2 Null Embryonic Stem
Cells: A System for Studying Rett Syndrome.
Brain Res. 1360(11): 17-27, 2010
Miyata S, Takemura G, Kosai K, Takahashi T, Esaki M, Li L, Kanamori H,
Maruyama R, Goto K, Tsujimoto A, Takeyama T, Kawaguchi T, Ohno T,
Nishigaki K, Fujiwara T, Fujiwara H, Minatoguchi S.
Anti-Fas Gene Therapy Prevents Doxorubicin-induced Acute Cardiotoxicity
through Mechanisms Independent of Apoptosis.
Am J Pathol. 176(2):687-98, 2010